2-219055032-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002181.4(IHH):​c.*175C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.595 in 682,856 control chromosomes in the GnomAD database, including 128,275 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23395 hom., cov: 33)
Exomes 𝑓: 0.62 ( 104880 hom. )

Consequence

IHH
NM_002181.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.481

Publications

14 publications found
Variant links:
Genes affected
IHH (HGNC:5956): (Indian hedgehog signaling molecule) This gene encodes a member of the hedgehog family of proteins. The encoded preproprotein is proteolytically processed to generate multiple protein products, including an N-terminal fragment that is involved in signaling. Hedgehog family proteins are essential secreted signaling molecules that regulate a variety of developmental processes including growth, patterning and morphogenesis. The protein encoded by this gene specifically plays a role in bone growth and differentiation. Mutations in this gene are the cause of brachydactyly type A1, which is characterized by shortening or malformation of the fingers and toes. Mutations in this gene are also the cause of acrocapitofemoral dysplasia. [provided by RefSeq, Nov 2015]
IHH Gene-Disease associations (from GenCC):
  • brachydactyly type A1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acrocapitofemoral dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-219055032-G-C is Benign according to our data. Variant chr2-219055032-G-C is described in ClinVar as Benign. ClinVar VariationId is 334429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IHHNM_002181.4 linkc.*175C>G 3_prime_UTR_variant Exon 3 of 3 ENST00000295731.7 NP_002172.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IHHENST00000295731.7 linkc.*175C>G 3_prime_UTR_variant Exon 3 of 3 1 NM_002181.4 ENSP00000295731.5

Frequencies

GnomAD3 genomes
AF:
0.522
AC:
79355
AN:
152024
Hom.:
23399
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.254
Gnomad AMI
AF:
0.525
Gnomad AMR
AF:
0.510
Gnomad ASJ
AF:
0.613
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.540
Gnomad FIN
AF:
0.737
Gnomad MID
AF:
0.579
Gnomad NFE
AF:
0.665
Gnomad OTH
AF:
0.510
GnomAD4 exome
AF:
0.616
AC:
327039
AN:
530714
Hom.:
104880
Cov.:
6
AF XY:
0.615
AC XY:
169551
AN XY:
275736
show subpopulations
African (AFR)
AF:
0.249
AC:
3486
AN:
14002
American (AMR)
AF:
0.509
AC:
10595
AN:
20806
Ashkenazi Jewish (ASJ)
AF:
0.622
AC:
8967
AN:
14420
East Asian (EAS)
AF:
0.293
AC:
9177
AN:
31368
South Asian (SAS)
AF:
0.553
AC:
26422
AN:
47774
European-Finnish (FIN)
AF:
0.736
AC:
29049
AN:
39492
Middle Eastern (MID)
AF:
0.572
AC:
1250
AN:
2184
European-Non Finnish (NFE)
AF:
0.667
AC:
221393
AN:
332116
Other (OTH)
AF:
0.585
AC:
16700
AN:
28552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6126
12251
18377
24502
30628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2102
4204
6306
8408
10510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
79355
AN:
152142
Hom.:
23395
Cov.:
33
AF XY:
0.525
AC XY:
39019
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.254
AC:
10528
AN:
41526
American (AMR)
AF:
0.510
AC:
7793
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.613
AC:
2126
AN:
3470
East Asian (EAS)
AF:
0.301
AC:
1553
AN:
5154
South Asian (SAS)
AF:
0.540
AC:
2604
AN:
4824
European-Finnish (FIN)
AF:
0.737
AC:
7808
AN:
10590
Middle Eastern (MID)
AF:
0.558
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
0.665
AC:
45235
AN:
67976
Other (OTH)
AF:
0.505
AC:
1065
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1725
3450
5176
6901
8626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.485
Hom.:
1669
Bravo
AF:
0.490
Asia WGS
AF:
0.330
AC:
1151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Apr 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Brachydactyly type A1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.3
DANN
Benign
0.67
PhyloP100
0.48
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3099; hg19: chr2-219919754; API